Background. Treatment of freezing of gait (FOG) is always challenging because of its
unpredictable nature and multifactorial physiopathology. Intestinal levodopa infusion has …

Background and purpose Treatment of freezing of gait (FoG) and other Parkinson disease
(PD) axial symptoms is challenging. Systematic assessments of axial symptoms at …

Objective To determine the impact of levodopa-carbidopa intestinal gel (LCIG) infusion on
different subtypes of freezing of gait (FoG) classified according to levodopa responsiveness …

Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized
pilot trial Page 1 Page 1/26 Subthalamic and Nigral Stimulation for Freezing of Gait in …

Objective We report a prospective, open label study of 24 h levodopa–carbidopa intestinal
gel (LCIG) as treatment for levodopa “unresponsive” freezing of gait (FOG) associated with …

Introduction Freezing of gait (FOG) is a highly disabling symptom in Parkinson's Disease
(PD) with varying degree of benefits from oral dopaminergic medications and several …

Freezing of gait is a common and disabling disorder in advanced Parkinson's disease (PD).
The relationship with dopaminergic medication is complex and often non-linear, thus …

Background: Treating medication-refractory freezing of gait (FoG) in Parkinson's disease
(PD) remains challenging despite several trials reporting improvements in motor symptoms …

Background and objectives Freezing of gait (FOG) is a disabling gait disorder in patients
with Parkinson's disease (PD), characterized by recurrent episodes of halting steps …

Although deep brain stimulation (DBS) has been reported to be effective to ameliorate motor
and non-motor dysfunctions, freezing of gait (FoG) is often resistant to DBS in patients with …